Email Updates

You are here

Home

27 MAY 2022 VOLUME 24 ISSUE 21

Media Coverage

  • ViiV ‘Actively Negotiating’ Voluntary License for HIV Prevention Drug

    GlaxoSmithKline’s ViiV Healthcare is “actively negotiating” a voluntary license on the patents for its injectable HIV prevention drug to make it more widely available in poorer nations, where fewer than a third of those at risk are on prophylactic treatment.

    May 27, 2022
    PrEP
    Financial Times

  • Home Packs Cut Time To Start HIV ‘Morning After Pill’ by Two-Thirds

    Last month’s British HIV Association (BHIVA) conference heard that providing gay and bisexual men with home packs of post-exposure prophylaxis (PEP) pills cut the average time between possible exposure and starting PEP from over a day to seven hours, but the majority of opportunities for prevention were still missed.

    May 26, 2022
    General
    aidsmap

  • Tanzania: Afya Kamilifu Project Launched to Control HIV Transmission

    The Amref Health Africa-Tanzania has officially launched "Afya Kamilifu' project in Mara Region, whose objectives are, among others, preventing new HIV transmissions. The project, which is sponsored by the US government through Centre for Disease Control and Prevention (CDC), also offers COVID-19 vaccinations to people living with HIV/AIDS and health service providers.

    May 26, 2022
    Treatment, Voluntary Medical Male Circumcision
    All Africa

  • Chile Apologizes to Woman Forcibly Sterilized for HIV Status

    Chile’s president publicly apologized to a woman who was sterilized without her consent at a public hospital two decades ago because she was HIV-positive, ending a years-long legal process that included taking her case to the Inter American Commission on Human Rights in Washington.

    May 26, 2022
    General
    The Washington Post

  • PLHIV in Australia Ineligible for Medicare Can Now Access Treatment Free of Charge

    People living with HIV in Australia who are ineligible for Medicare will soon be able to access treatment free of charge. From July 1, individuals with HIV will be able to access their treatment by going to government-funded hospital pharmacies.

    May 25, 2022
    Treatment
    Star Observer

  • Using Antibiotics To Prevent STIs Found Effective in Early SF Study Results

    UCSF researchers studying the use of antibiotics to prevent sexually transmitted infections in high-risk individuals abruptly stopped enrolling new participants in a clinical trial this month after early results showed the intervention was effective and it would be unethical not to offer it more widely.

    May 25, 2022
    General
    San Francisco Chronicle

  • Oracle and NIH Networks Launch Registry to Help End HIV/AIDS

    The HIV Vaccine Trials Network has launched a new HIV awareness campaign — the Red Ribbon Registry — to help end HIV. Built by Oracle, the unique cloud-based registry makes it easy for anyone to volunteer to be considered for an HIV clinical study — increasing the chances of finding a cure, said the partners.

    May 25, 2022
    General
    The Washington Informer

  • Steep But Deceptive Drop in HIV Diagnoses in 2020

    When is a drop in new diagnoses not a win for ending the HIV epidemic? When that drop comes amid a global pandemic that has reduced HIV testing and other services, according to new surveillance data from the Centers for Disease Control and Prevention (CDC).

    May 25, 2022
    General
    POZ

  • Hiring People of Color

    Change is hard. It requires great effort and lots of anxiety. Many White-led HIV and LGBTQ agencies recently hired their first person of color to lead the nonprofit. I’m very proud because so many have fought for so long for this representation. At the same time, I worry for our new colleagues’ success. Will these leaders be judged by a different standard? The unfortunate reality is “yes.”

    May 25, 2022
    General
    POZ

  • Due to COVID, 2020 Was a ‘Lost Year’ in the Fight Against HIV, Report Suggests

    Confronted by the COVID-19 pandemic, an ambitious new plan by the federal government, marshaled by Dr. Anthony Fauci, to accelerate the battle against the stubbornly persistent HIV epidemic in the US appears to have made a markedly disappointing debut.

    May 24, 2022
    General
    NBC News

  • Davos Booster for $18 Billion Fund to Fight AIDS, Tuberculosis and Malaria

    A global health fund has raised a third of the $18 billion it says is needed to reverse setbacks caused by the coronavirus pandemic and combat AIDS, malaria and tuberculosis.

    May 24, 2022
    General
    US News & World Report

  • Health Care Access for Trans Women With HIV

    Women of transgender experience in the United States were 12 percent more likely to receive HIV care and 79 percent more likely to take HIV prevention pills in 2019 and 2020 if they had a gender-affirming healthcare provider, according to data published in Morbidity and Mortality Weekly Report.

    May 24, 2022
    General
    POZ

  • mRNA HIV Vaccine Development Programme Launches in Africa

    With the participation of experts from Africa, inroads are being made into an mRNA HIV vaccine. The non-profit scientific research organisation, International AIDS Vaccine Initiative (IAVI) and Moderna announced that the first participant screenings for a Phase I clinical trial of an mRNA HIV vaccine are going to start soon at the Centre for Family Health Research (CFHR) in Kigali, Rwanda, and The Aurum Institute in Tembisa, South Africa.

    May 23, 2022
    HIV Vaccine
    Health-E News

  • Ahead of Vaginal Ring Introduction in Sub-Saharan Africa, Potential End-Users Express Several Concerns

    Almost 50 percent of Kenyan women interested in using the dapivirine vaginal ring are willing to pay up to 100 shillings (less than one dollar) for it. Thirty-nine per cent would pay between 100-400 shillings ($0.94-$3.72), while only 14 percent would pay above four hundred shillings, according to a report presented last week at the INTEREST 2022 conference in Kampala.

    May 23, 2022
    Microbicides
    aidsmap

  • Can the US End HIV? Not With Its Current Approach, Experts Warn

    Two federal initiatives aim to significantly reduce HIV incidence in the US and eliminate longstanding racial, ethnic, and geographic disparities in HIV prevention efforts. But some HIV experts say these initiatives are likely to fall short of their goals because of funding shortfalls and structural racism—and could, despite their best intentions, already be doomed. That possible failure, they say, would be due to the gross, longstanding inequities that have kept transmission rates in Black and Latinx communities stubbornly high.

    May 23, 2022
    General
    The BodyPro

  • Monkeypox Isn’t Like HIV, but Gay and Bisexual Men Are at Risk of Unfair Stigma

    The first case of monkeypox in the current outbreak was reported to the World Health Organization (WHO) on May 7. The person in question had recently returned to the UK from Nigeria, where they are believed to have contracted the infection. Since then, further cases have been reported in over a dozen countries where the disease is not normally present, including several European countries, Israel, the US and Canada, as well as Australia.

    May 23, 2022
    General
    The Conversation

  • ‘Nothing for Us Without Us’: Achieving Epidemic Control Among Key Populations in Africa

    While some countries in Africa are on the verge of reaching epidemic control – which means there are fewer HIV diagnoses than deaths of people with HIV – progress among key populations remains largely unknown, participants at the INTEREST 2022 conference in Kampala heard last week. In 2020, key populations and their sexual partners accounted for 39 percent of new HIV acquisitions in sub-Saharan Africa. However, only eight countries had prevalence data on people who inject drugs, while just two had data on transgender people.

    May 21, 2022
    PrEP, Treatment
    aidsmap

Published Research

Announcements